Moreover, S6Ks also play key roles in the progression, survival, migration, and response to chemotherapy drugs of prostate cancer, indicating that S6K is a promising target for advanced prostate cancer treatment [42]. This evidence concerns the gene RPS6KB1 and prostate carcinoma.